Sanara MedTech Inc. (SMTI) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
SMTI Revenue Growth
Revenue Breakdown (FY 2023)
SMTI's revenue distribution by segment and geography for fiscal year 2023
By Product/Segment
SMTI Revenue Analysis (2014–2025)
As of May 8, 2026, Sanara MedTech Inc. (SMTI) generated trailing twelve-month (TTM) revenue of $103.1 million, reflecting modest growth of +4.6% year-over-year. The most recent quarter (Q4 2025) recorded $27.5 million in revenue, up 4.5% sequentially.
Looking at the longer-term picture, SMTI's 5-year compound annual growth rate (CAGR) stands at +45.9%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $103.1 million in 2025, representing a new all-time high.
Revenue diversification analysis shows SMTI's business is primarily driven by Royalty (100%). With over half of revenue concentrated in Royalty, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including NVCR (+8.5% YoY), XTNT (+16.9% YoY), and MDXG (+10.5% YoY), SMTI has underperformed the peer group in terms of revenue growth. Compare SMTI vs NVCR →
SMTI Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SMTICurrent | $103M | +4.6% | +45.9% | 7.1% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 XTNT | $117M | +16.9% | +12.6% | -10.3% | |
 MDXG | $419M | +10.5% | +11.0% | 15.3% | |
 KROS | $244M | +6775.0% | - | 28.9% | |
 BLCO | $5.1B | +7.8% | +8.4% | 3.7% |
SMTI Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $103.1M | +19.0% | $95.6M | 92.7% | $7.3M | 7.1% |
| 2024 | $86.7M | +33.4% | $78.5M | 90.6% | $-6,715,474 | -7.7% |
| 2023 | $65.0M | +41.8% | $57.1M | 87.9% | $-4,215,153 | -6.5% |
| 2022 | $45.8M | +89.9% | $39.5M | 86.1% | $-12,517,180 | -27.3% |
| 2021 | $24.1M | +54.9% | $21.8M | 90.4% | $-7,376,157 | -30.6% |
| 2020 | $15.6M | +32.5% | $14.0M | 89.6% | $-5,034,613 | -32.3% |
| 2019 | $11.8M | +101.6% | $10.6M | 89.7% | $-2,740,057 | -23.3% |
| 2018 | $5.8M | -7.4% | $5.3M | 91.3% | $-501,860 | -8.6% |
| 2017 | $6.3M | +14.5% | $5.5M | 87.2% | $120K | 1.9% |
| 2016 | $5.5M | +63.3% | $4.6M | 82.9% | $-272,133 | -4.9% |
See SMTI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SMTI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SMTI vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSMTI — Frequently Asked Questions
Quick answers to the most common questions about buying SMTI stock.
Is SMTI's revenue growth accelerating or slowing?
SMTI revenue growth slowed to +4.6%, below the 5-year CAGR of +45.9%. TTM revenue is $103M. The deceleration marks a shift from historical growth rates.
What is SMTI's long-term revenue growth rate?
Sanara MedTech Inc.'s 5-year revenue CAGR of +45.9% reflects the variable expansion pattern. Current YoY growth of +4.6% is near this long-term average.
How is SMTI's revenue distributed by segment?
SMTI reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.